Chapter 4: Legal and Professional Issues in Prescribing

Pharmacotherapeutics for Nurse Practitioner Prescribers 3rd Edition by Teri Moser Woo

$2.99

Chapter 4: Legal and Professional Issues in Prescribing

 

Complete Chapter Questions With Answers

 

Sample Questions Are Posted Below

 

Multiple Choice

Identify the choice that best completes the statement or answers the question.

 

____     1.   The U.S. Food and Drug Administration (FDA) regulates:

A. Prescribing of drugs by MDs and NPs
B. The official labeling for all prescription and over-the-counter drugs
C. Off-label recommendations for prescribing
D. Pharmaceutical educational offerings

 

 

____     2.   The U.S. Food and Drug Administration (FDA) approval is required for:

A. Medical devices, including artificial joints
B. Over-the-counter vitamins
C. Herbal products, such as St John’s Wort
D. Dietary supplements, such as Ensure

 

 

____     3.   An Investigational New Drug (IND) is filed with the FDA:

A. When the manufacturer has completed Phase III trials
B. When a new drug is discovered
C. Prior to animal testing of any new drug entity
D. Prior to human testing of any new drug entity

 

 

____     4.   Phase IV clinical trials in the United States are also known as:

A. Human bioavailability trials
B. Post-marketing research
C. Human safety and efficacy studies
D. The last stage of animal trials before the human trials begin

 

Answer Section

 

MULTIPLE CHOICE

 

  1. ANS:  B                    PTS:   1

 

  1. ANS:  A                    PTS:   1

 

  1. ANS:  D                    PTS:   1

 

  1. ANS:  B                    PTS:   1

Additional information

Add Review

Your email address will not be published. Required fields are marked *